CHEK2*1100delC is not an important high-risk gene in families with hereditary prostate cancer in southern Sweden

Magnus Wagenius, Åke Borg, Lovisa Johansson, Aleksander Giwercman, Ola Bratt

Scandinavian Journal of Urology and Nephrology · 2006 · 17 citations · 13 references

Abstract

The CHEK2 1100delC mutation is not a clinically important high-risk gene for hereditary prostate cancer susceptibility in the population of southern Sweden.

References

13